4.2 Article

The secondary bile acid, deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc min/+ mice through enhancing Wnt signaling

Journal

FAMILIAL CANCER
Volume 13, Issue 4, Pages 563-571

Publisher

SPRINGER
DOI: 10.1007/s10689-014-9742-3

Keywords

Deoxycholate; Intestinal tumor; Apc(min/+) mice; Wnt signaling

Funding

  1. National Natural Science Foundation of China [81300272, 81070283]
  2. Research Fund for the Doctoral Program of Higher Education of China [20121202110018]
  3. Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600]

Ask authors/readers for more resources

Colorectal cancer is one of the leading causes of cancer deaths. It correlates to a high fat diet, which causes an increase of the secondary bile acids including deoxycholate (DOC) in the intestine. We aimed to determine the effects of DOC on intestinal carcinogenesis in Apc (min/+) mice, a model of spontaneous intestinal adenomas. Four-week old Apc (min/+) mice were treated with 0.2 % DOC in drinking water for 12 weeks. The number and size of tumors were measured, and tissue sections were prepared for the evaluation of intestinal carcinogenesis, cell proliferation, and apoptosis. The activation of Wnt signaling was detected in the intestinal tumor cells of the Apc (min/+) mice, and also in the human colon samples. DOC increased the number of intestine tumors by 165.1 % compared with that in untreated Apc (min/+) mice mainly in the middle and distal segments of the small intestine and colon. The numbers of all sizes of tumors in the small intestine were increased. Intestinal carcinogenesis was confirmed in 75 % mice in DOC treated-Apc (min/+) mice compared with 0 % in untreated mice. This was accompanied by promoting tumor cell proliferation and decreasing apoptosis, and increasing the percentage of beta-catenin positive cells and its nuclear expression in intestinal tumor cells of Apc (min/+) mice, and also up-regulating the expression of cyclin D1. In addition, the activation of Wnt signaling also played in modulating human colon carcinogenesis. Our studies suggest that DOC enhances the multiplicity of intestinal tumor, and accelerates intestinal adenoma-adenocarcinoma sequence in Apc (min/+) mice mediated by stimulating tumor cell proliferation and decreasing apoptosis through enhancing Wnt signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Agriculture, Multidisciplinary

Nobiletin Attenuates DSS-Induced Intestinal Barrier Damage through the HNF4α-Claudin-7 Signaling Pathway

Xiang Wen, Hui Zhao, Liwen Wang, Liang Wang, Gang Du, Wenqiang Guan, Jianfu Liu, Xiaocang Cao, Xiaohua Jiang, Jingrui Tian, Meiyan Wang, Chi-Tang Ho, Shiming Li

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Article Biotechnology & Applied Microbiology

Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice

Bai Liang, Gao Mengxue, Cheng Xiaoming, Kang Guangbo, Cao Xiaocang, Huang He

MICROBIAL CELL FACTORIES (2020)

Article Medicine, Research & Experimental

Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress

Liyun Duan, Haoyan Huang, Xiaotong Zhao, Manqian Zhou, Shang Chen, Chen Wang, Zhibo Han, Zhong-Chao Han, Zhikun Guo, Zongjin Li, Xiaocang Cao

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Review Immunology

Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine

Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun

Summary: Bicyclol, a novel chemical drug derived from Schisandra chinensis, shows therapeutic potential in various liver conditions with a wide range of pharmacological properties. Pharmacokinetic studies indicate its safety and lack of drug interactions, making it a potential candidate for liver diseases worldwide. Further research is needed to understand its molecular mechanisms for increased potency in clinical use.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Letter Gastroenterology & Hepatology

Elective Switching on Biosimilars: Far More Than Nonmedical Switching

Xiaocang Cao, Haibin Yuan, Jie Liang, He Huang

INFLAMMATORY BOWEL DISEASES (2022)

Review Immunology

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment

Jiewen Wang, Guangbo Kang, Haibin Yuan, Xiaocang Cao, He Huang, Ario de Marco

Summary: Recombinant antibodies like nanobodies are proving to be a valuable alternative to conventional monoclonal antibodies in clinical applications, with unique features that expand biotherapeutic options and alter disease treatment paradigms.

FRONTIERS IN IMMUNOLOGY (2022)

Article Microbiology

Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice

Lina Wang, Xiaoming Cheng, Liang Bai, Mengxue Gao, Guangbo Kang, Xiaocang Cao, He Huang

Summary: This study demonstrated that continuous consumption of engineered butyrate-producing bacteria had a significant inhibitory effect on obesity induced by a high-fat diet. The bacteria not only improved glucose and lipid metabolism but also regulated gut microbe composition. This research provided a new strategy for the effective and convenient treatment of obesity in the long term.

MICROBIOLOGY SPECTRUM (2022)

Review Immunology

Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease

Xiaoli Wang, Jingwen Zhao, Yuanhang Feng, Zelin Feng, Yulin Ye, Limin Liu, Guangbo Kang, Xiaocang Cao

Summary: The intestinal microbiome plays a crucial role in human health and disease, and microbiota transplantation is considered as a potential therapy for chronic diseases such as inflammatory bowel disease. Transplanting genetically diverse gut microbiota with metabolic flexibility and functional redundancy can effectively improve gut health. Natural fecal microbiota transplantation or washing microbiota transplantation has shown positive effects in alleviating colitis and improving intestinal dysbiosis. However, the complex and unclear composition of the flora limits its wider application.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Gastroenterology & Hepatology

Modeling spatial interaction networks of the gut microbiota

Xiaocang Cao, Ang Dong, Guangbo Kang, Xiaoli Wang, Liyun Duan, Huixing Hou, Tianming Zhao, Shuang Wu, Xinjuan Liu, He Huang, Rongling Wu

Summary: This study integrates different theories to infer quasi-dynamic microbial networks from static abundance data, revealing various characteristics of microbial interactions and demonstrating their dynamic adaptability across space.

GUT MICROBES (2022)

Review Medicine, Research & Experimental

Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies

Zelin Feng, Guangbo Kang, Jiewen Wang, Xingjie Gao, Xiaoli Wang, Yulin Ye, Limin Liu, Jingwen Zhao, Xinjuan Liu, He Huang, Xiaocang Cao

Summary: Emerging biologics and small-molecule drugs have changed the treatment landscape of inflammatory bowel disease (IBD), but dual-targeted therapy (DTT) shows promise in overcoming treatment limitations. However, limited data on efficacy, safety, and mechanisms of DTT for Crohn's disease and ulcerative colitis exist. This review summarizes current data on novel targeted drugs for refractory IBD, categorizes therapeutic agents based on targets, and proposes mechanisms of DTT to aid clinical decision-making and future drug development.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Multidisciplinary Sciences

Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis

Juan Du, Junlei Zhang, Lin Wang, Xun Wang, Yaxing Zhao, Jiaoying Lu, Tingmin Fan, Meng Niu, Jie Zhang, Fei Cheng, Jun Li, Qi Zhu, Daoqiang Zhang, Hao Pei, Guang Li, Xingguang Liang, He Huang, Xiaocang Cao, Xinjuan Liu, Wei Shao, Jianpeng Sheng

Summary: By using imaging mass cytometry and single-cell RNA sequencing, researchers characterized the single-cell landscape of the human colon ecosystem in ulcerative colitis. They found tissue topological changes and a disappearance reaction of tissue-resident macrophages in the ulcerative colitis region. The study also revealed different reactive oxygen species vulnerability between inflammatory macrophages and resident macrophages, as well as a cytokine production network formed with T and B cells.

NATURE COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn's disease

Rirong Chen, Li Li, Kang Chao, Mengzhi Hong, Qian Cao, Lingna Ye, Gaoshi Zhou, Xiaoli Fang, Huili Guo, Xiaocang Cao, Xiaoqi Ye, Zhirong Zeng, Minhu Chen, Shenghong Zhang

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)

Article Cell & Tissue Engineering

Spatio-Temporal Metabolokinetics and Efficacy of Human Placenta-Derived Mesenchymal Stem/Stromal Cells on Mice with Refractory Crohn's-like Enterocutaneous Fistula

Huixing Hou, Leisheng Zhang, Liyun Duan, Yuanyuan Liu, Zhongchao Han, Zongjin Li, Xiaocang Cao

STEM CELL REVIEWS AND REPORTS (2020)

Article Medicine, Research & Experimental

IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE(2)-mediated M2 macrophage polarization

Xiaocang Cao, Liyun Duan, Huixing Hou, Yue Liu, Shang Chen, Shuaiqiang Zhang, Yuanyuan Liu, Chen Wang, Xin Qi, Na Liu, Zhibo Han, Dekui Zhang, Zhong-Chao Han, Zhikun Guo, Qiang Zhao, Zongji Li

THERANOSTICS (2020)

Article Medicine, Research & Experimental

Prostaglandin E-2 hydrogel improves cutaneous wound healing via M2 macrophages polarization

Shuaiqiang Zhang, Yuanyuan Liu, Xin Zhang, Dashuai Zhu, Xin Qi, Xiaocang Cao, Yihu Fang, Yongzhe Che, Zhong-Chao Han, Zuo-Xiang He, Zhibo Han, Zongjin Li

THERANOSTICS (2018)

No Data Available